lomustine

The drug is used for palliative therapy of brain tumors (primary and metastatic), lung tumors (especially small cell carcinoma), Hodgkin's disease that is resistant to traditional treatment, malignant melanoma with metastases, and as a second-line agent in the treatment of non-Hodgkin lymphoma.

Form: capsules

ATC: L01AD02

Manufacturer: Medac Gesellschaft für klinische Spezialpräparate mbH (manufacturer responsible for primary packaging labeling, secondary packaging, control/testing of batch and batch release)